Inside Trump’s $1.8 B Anti-Weaponization Fund: Allocation, Oversight, and Legal Risks

Trump’s $1.776 billion Anti-Weaponization Fund emerged from a settlement that barred the IRS from auditing his returns and offered a formal apology. The fund is financed by ↑ $1.776 billion of taxpayer money and will run through December 2028.

How the Anti-Weaponization Fund operates

Acting Attorney General Todd Blanche, a former criminal defense lawyer for the ex‑president, appointed a five‑member commission that alone decides who receives payouts, and those decisions are insulated from judicial review. The settlement imposes no public disclosure requirement, allowing the Justice Department to allocate money without external scrutiny.

Eligibility and scope

Anyone claiming “weaponization” or “lawfare” can apply, Blanche told a Senate Appropriations subcommittee, even individuals convicted of assaulting Capitol Police; he declined to set exclusion rules. Vice President Katherine Vance added that even figures such as Colorado clerk Tina Peters or Hunter Biden could qualify.

“The most brazen act of presidential corruption this century,” said former Capitol Police Officer Harry Dunn, filing a lawsuit to dissolve the fund under the 14th Amendment.

The litigation argues the fund violates the amendment’s bar on paying debts incurred in aid of insurrection. Critics cite the 1956 Judgment Fund, originally designed for swift settlement payments, as the legal conduit; its cap of ↓ $100,000 was lifted in 1978, opening the door for massive, unchecked disbursements. Paul Figley, a 32‑year Justice Department veteran, warned that Congress left a “huge loophole” that any administration could exploit until reforms are enacted. The Obama‑era $760 million Keepseagle settlement for Native American farmers is touted as precedent, yet that case required a federal judge’s approval after protracted litigation. Reuters and Bloomberg have highlighted the fund’s opaque structure, while a recent pandemic‑era relief program showed how similar mechanisms can bypass congressional scrutiny.